Posts tagged “GSK”
Drug giant GlaxoSmithKline is shipping the first few hundred doses of its vaccine that is being tested as a treatment for Ebola to Africa for further testing. GSK will soon begin testing the vaccine for efficacy. Currently there is no successful treatment for the deadly disease.
GSK layoffs in China?; Lenovo-Xiamoi showdown; NC wind energy study; China blocks VPNs; Box prices IPO; Uber woes; Verizon loss
In today's Bulldog wrapup: GSK reportedly will lay off 1,000 in China; Lenovo takes on Xiaomi with own cheap smartphone in India; feds seek public input on coastal NC wind energy study; China shutting down virtual private networks; Box prices its IPO; Denmark may ban Uber; and Verizon reports a quarterly loss.
Doctors without Borders vs. GSK; Etix founder buys Hopscotch; Facebook hoax crackdown; Netflix surges; Twitter buys ZipDial
In today's Bulldog wrapup of life science and technology news: Doctors Without Borders calls on GSK, Pfizer to cut vaccine prices; Etix founder buys Raleigh's Hopscotch Music Festival; Facebook cracks down on hoaxes; Netflix growth surges; and Twitter makes an acquisition to grow in developing nations.
Veteran journalist Jim Shamp sees upside and downside in the recently announced job cuts at GlaxoSmithKline. After all, he notes, cuts in the past as GSK evolved locally from Burrough Wellcome to Glaxo to Glaxo Wellcome and today have produced a harvest of new companies, new ideas, and products. "Yes, a shakeup like GSK's cutback announcement is shattering," he writes. "But these are smart, talented people who will get back on their feet and contribute greatly to North Carolina's life science future."
RTP-based BioCryst Pharmaceuticals is launching a clinical trial of a potential treatment for Ebola with funding support from the U.S. government. Durham-based Chimerix and GSK also are involved in the Ebola battle.
Even as backers pledged $390 million for Ebola vaccines, Swiss researchers have suspended the testing of one of the leading Ebola vaccine candidates after some volunteers reported unexpected side effects. It's not the vaccine being tested by GlaxoSmithKline.
Several North Carolina firms are at the forefront of developing new treatments for the Ebola virus, but they face challenges in testing and delivering them, executives from Chimerix, Quintiles and GlaxoSmithKline say at a conference in RTP.
Dr. Derek Lowe, a veteran pharmaceutical scientist and long-time Internet blogger, was among the first to report details of GSK's 20% job force reduction in RTP. Fed information from friends and contacts within the industry, he has written several insightful blogs about what's happening at the drug giant and across the pharmaceutical industry, particularly in R&D. And he tells WRAL TechWire that GSK's cuts are a "severe blow" to the Triangle.
GlaxoSmithKline will lay off hundreds of research and development workers at its Research Triangle Park campus, the company said in an official notice to the state.
Up to 450 employees of drug giant GlaxoSmithKline who face being laid off may find employment quickly at Parexel, a life science research firm with an office in RTP. GSK says it has signed a letter of intent to create a GSK-focused group within Parexel.
Trending in the Triangle: Get the pulse of technology in the Triangle with the best in local technology, venture, biotech, and life science news on Wednesday, Dec. 3, 2014 as curated by @WRALTechWire.
In a statement, GlaxoSmithKline explains the cutbacks being made in research and development at Research Triangle Park and other locations. "Our proposed changes to R&D will sharpen the focus in discovery and development and reduce funding in certain areas of the pipeline," the drug giant says.
GlaxoSmithKline is preparing to lay off hundreds of workers in the U.S., according to various media reports. A company spokesperson in RTP, where the company operates its North American headquarters, confirms that a reorganization is underway but won't comment on specifics.
The Ebola outbreak isn't generating big headlines in the U.S. these days, but forthcoming layoffs at GlaxoSmithKline are a hot topic. Unfortunately for GSK, the job cuts have overshadowed the company's progress in developing the first vaccine for the deadly Ebola.
A new survey from the Human Rights Campaign finds that a record number of companies, including seven in North Carolina, received perfect scores in corporate inclusion for lesbian, gay, bisexual and transgender employees. Bank of America, Blue Cross Blue Shield of NC and GlaxoSmithKline are among those receiving a "100" on the Corporate Equality Index.